α-methyl-p-tyrosine inhibits latanoprost-induced melanogenesis in vitro

被引:34
|
作者
Drago, F [1 ]
Marino, A [1 ]
La Manna, C [1 ]
机构
[1] Univ Catania, Sch Med, Fac Med, Inst Pharmacol, I-95125 Catania, Italy
关键词
melanogenesis; alpha-methyl-p-tyrosine; latanoprost; iris pigmentation; glaucoma;
D O I
10.1006/exer.1998.0581
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
The PGF2 alpha derivative, latanoprost, is a recent anti-glaucoma drug that has been reported to induce a discrete incidence of increased iris pigmentation in men. The present experiments were made in order to study whether this phenomenon could be influenced by the tyrosinase inhibitor, alpha-methyl-p-tyrosine. Melanin content, melanin production and tyrosinase activity of cultured uveal melanocytes derived from irides of brown or brown-blue color were measured after adding latanoprost at different molar concentration with or without a-methyl-p-tyrosine (10(-5) M). It was shown that latanoprost stimulated melanin content, melanin production and tyrosinase activity in a molar range between 10(-7) and 10(-5) M in uveal melanocytes derived from irides of both brown and brown-blue color. The effect seemed to be more pronounced in melanocytes derived from irides of brown-blue color. The adding of alpha-methyl-p-tyrosine completely prevented latanoprost-induced stimulation of melanin production in uveal melanocytes derived from irides of both colors. These results suggest that latanoprost-induced stimulation of melanin production, follows the metabolic pathway involving tyrosinase activity and may be relevant for the therapeutic application of latanoprost in glaucoma in order to reduce its side-effect resulting in increased iris pigmentation. (C) 1999 Academic Press.
引用
收藏
页码:85 / 90
页数:6
相关论文
共 50 条
  • [1] Hyperleptinaemia in mice induced by administration of the tyrosine hydroxylase inhibitor α-methyl-p-tyrosine
    Rayner, DV
    Simón, E
    Duncan, JS
    Trayhurn, P
    FEBS LETTERS, 1998, 429 (03) : 395 - 398
  • [2] METHYL-P-TYROSINE EFFECT ON GONADOTROPIN AND PROLACTIN PITUITARY RELEASE IN WOMEN
    NICOLETTI, I
    FILIPPONI, P
    FEDELI, L
    SANTEUSANIO, F
    BRUNETTI, P
    HORMONE AND METABOLIC RESEARCH, 1981, 13 (05) : 299 - 300
  • [3] Stress-induced increase in urinary isatin excretion in rats -: Reversal by both dexamethasone and α-methyl-P-tyrosine
    Tozawa, Y
    Ueki, A
    Manabe, S
    Matsushima, K
    BIOCHEMICAL PHARMACOLOGY, 1998, 56 (08) : 1041 - 1046
  • [4] EFFECTS OF ALPHA METHYL-P-TYROSINE ON EXPLORATORY-BEHAVIOR IN 2 RAT STRAINS
    SCHLATTER, J
    BATTIG, K
    EXPERIENTIA, 1977, 33 (06): : 809 - 809
  • [5] DECREASED SEPTAL-FOREBRAIN AND LATERAL HYPOTHALAMIC REWARD AFTER ALPHA METHYL-P-TYROSINE
    COOPER, BR
    BLACK, WC
    PAOLINO, RM
    PHYSIOLOGY & BEHAVIOR, 1971, 6 (04) : 425 - &
  • [6] Comparison of the effects of α-methyl-p-tyrosine and a tyrosine-free amino acid load on extracellular noradrenaline in the rat hippocampus in vivo
    McTavish, SFB
    Callado, L
    Cowen, PJ
    Sharp, T
    JOURNAL OF PSYCHOPHARMACOLOGY, 1999, 13 (04) : 379 - 384
  • [7] D2 autoreceptors are not involved in the down-regulation of the striatal dopamine transporter caused by α-methyl-p-tyrosine
    Han, S
    Rowell, PP
    Carr, LA
    RESEARCH COMMUNICATIONS IN MOLECULAR PATHOLOGY AND PHARMACOLOGY, 1999, 104 (03) : 331 - 338
  • [8] Effects of lead exposure on GnRH and LH secretion in male rats:: Response to castration and α-methyl-p-tyrosine (AMPT) challenge
    Sokol, RZ
    Berman, N
    Okuda, H
    Raum, W
    REPRODUCTIVE TOXICOLOGY, 1998, 12 (03) : 347 - 355
  • [9] Effect of amphetamine, α-methyl-p-tyrosine (α-MPT) and antipsychotic agents on dopamine D2-type receptor occupancy in rats
    Lahti, RA
    Tamminga, CA
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 1999, 23 (07): : 1277 - 1283
  • [10] Development of early diagnosis of Parkinson's disease on animal models based on the intranasal administration of α-methyl-p-tyrosine methyl ester in a gel system
    Kim, Alexander
    Pavlova, Ekaterina
    Kolacheva, Anna
    Bogdanov, Vsevolod
    Dilmukhametova, Liliya
    Blokhin, Viktor
    Valuev, Lev
    Valuev, Ivan
    Gorshkova, Marina
    Ugrumov, Michael
    BIOMEDICINE & PHARMACOTHERAPY, 2022, 150